Atlas Trials

Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC

Clinical trial NCT03175705 · UNKNOWN

Trial details

NCT number
NCT03175705
Sponsor
Beijing YouAn Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2017-05-01
Primary completion
2018-12-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.